Behind the Bastards
Part Two: The Vioxx Scandal: How Big Pharma Killed More Americans Than Vietnam
Robert Evans
In March 2000, when Merck became aware of the Vigor study's findings of a significant increase in cardiovascular events for those taking Vioxx over naproxen, Merck's scientists expressed concern. In an email message written in March of 2000, Dr. Edward Skolnick, who was then Merck's head of research, stated the Vigor clinical trial had shown that Vioxx increased heart risks.
0
💬
0
Comments
Log in to comment.
There are no comments yet.